Showing results (241-250 of 511) with videos related to
Sort By:
Pageof 52
Med (New York, N.Y.)|November 8, 2024
Recurrent late-onset neutropenia following treatment with different B cell-depleting strategies in multiple sclerosisMaria Protopapa, Muriel Schraad, Katrin Pape, et al.Family Medicine|September 13, 2022
The Predictive Value of the Residency AOBFP In-Service Exam, Produced and Administered by ACOFPJonathan W Torres, John R Bowling, Christopher Zipp, et al.Journal of Neuroimmunology|April 1, 1998
CD95 expression and CD95-mediated apoptosis of T cells in multiple sclerosis. No differences from normal individuals and no relation to HLA-DR2F Zipp, E Faber, N Sommer, et al.AJNR. American Journal of Neuroradiology|May 19, 2012
Clinical standardized fMRI reveals altered language lateralization in patients with brain tumorS Partovi, B Jacobi, N Rapps, et al.Therapeutic Advances in Neurological Disorders|December 26, 2022
Comparative effectiveness of natalizumab versus ocrelizumab in multiple sclerosis: a real-world propensity score-matched studyKatrin Pape, Leoni Rolfes, Falk Steffen, et al.Immunology|February 16, 2011
Analyses of phenotypic and functional characteristics of CX3CR1-expressing natural killer cellsIsabell Hamann, Nadine Unterwalder, Astrid E Cardona, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 15, 2002
Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brainJan Dörr, Ingo Bechmann, Sonia Waiczies, et al.Stem Cells (Dayton, Ohio)|September 8, 2007
Neural cell adhesion molecule polysialylation enhances the sensitivity of embryonic stem cell-derived neural precursors to migration guidance cuesTamara Glaser, Claudia Brose, Isabelle Franceschini, et al.Trends in Pharmacological Sciences|June 19, 2007
Impact of HMG-CoA reductase inhibition on brain pathologyFrauke Zipp, Sonia Waiczies, Orhan Aktas, et al.International Journal of Clinical and Experimental Medicine|April 23, 2014
Hybrid PET/MR imaging in two sarcoma patients - clinical benefits and implications for future trialsSasan Partovi, Andres A Kohan, Lisa Zipp, et al.Pageof 52